Yuanteng Jeff Li

4PUBLICATIONS
16CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Dermatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 31, 2026
Immune hallmarks of recurrent immune checkpoint inhibitor-mediated inflammatory arthritis.

|May 20, 2026
Dose reduction and discontinuation of non-tumor necrosis factor (TNF) biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) for people with rheumatoid arthritis in remission or low disease activity.

|Aug 30, 2024
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series.

Yuanteng Jeff Li, Pavlos Msaouel, Matthew Campbell

|Nov 28, 2023
Case of new-onset scleromyxoedema-scleroedema spectrum disorder in a patient with CLL.

Yuanteng Jeff Li, Victor G Prieto, Jean Tayar

Pageof 1

Frequent Collaborators

2 joint publications

Jean H Tayar

2 joint publications

Sang T Kim

1 joint publications

Maria Angeles Lopez-Olivo

1 joint publications

Yimin Geng